4th Adverse Event Reporting and Safety Strategies Summit -

4th Adverse Event Reporting and Safety Strategies Summit
December 4 - 5, 2017
Philadelphia, PA

Harmonize and Comply with Adverse Event Management Regulations and Enhance Pharmacovigilance Strategies

4th Adverse Event Reporting and Safety Strategies Summit – 4th Adverse Event Reporting and Safety Strategies Summit

Adverse events are the pillars of pharmacovigilance and safety operations as we know them. They are the drivers for developing safety databases, risk management plans, risk evaluation and mitigation strategies, benefit-risk assessments, and periodic reports. Their collection and reporting is instrumental in leading to preventative actions for marketing better and safer drugs.

The 4th Adverse Event Reporting and Safety Strategies Summit illuminates and disseminates best practices in pharmacovigilance and adverse events management. Attendees will explore lessons learned and replicate best practices of our illustrious speaking faculty of regulators and industry-leading practitioners, and other experts.

The pharmacovigilance space is constantly evolving — as are the needs of professionals and stakeholders in this area. In order to promote patient safety, proactively monitor adverse events and understand their impact in every phase of development, it is crucial to keep up to date with the latest regulatory changes, innovations and emerging technologies.

This summit is expressly designed for PV professionals and stakeholders seeking to ensure global compliance and improve their company’s effectiveness in adverse events reporting, drug safety management and risk mitigation. The summit disseminates best practices of life sciences companies to detect and prevent adverse reactions that positively impact drug safety profiles by illuminating tactics for related to benefit-risk assessment, real-world data solutions and analyses, signal detection, periodic reporting and solicited/unsolicited reports.

Top Five Reasons to Attend

  1. Harmonize PV globally in compliance with the disparate expectations and timelines of regulatory authorities
  2. Prepare comprehensive reports by optimize signal detection in enhancing data collection and mining methods
  3. Improve safety through robust safety governance and internal audits of risk management efficiency assessments
  4. Execute tactics and leveraging tools for measuring risk management efficiency to better identify potential and prevent adverse events
  5. Vet emerging technologies, solutions and partner strategies to streamline global safety operations and reporting

Who Should Attend

This conference is designed for professionals from pharmaceutical, biotech and medical device companies with responsibilities in the following areas:

  • Pharmacovigilance
  • Drug Safety
  • Risk Management
  • Safety Research/Epidemiology
  • Pharmacoepidemiology
  • Medical Product Safety Assessment
  • Regulatory Affairs
  • Clinical Research
  • Safety Surveillance
  • Signal Detection
  • Clinical Safety
  • Patient/Medical Safety
  • Health Outcomes
  • Phase IV/Postmarketing Safety

This conference is also of interest to:

  • Adverse Event/Case Management Service Providers
  • Safety Database Providers for Case Management
  • CROs
  • PV Services Providers and Consultants
  • Healthcare/Pharmacovigilance Consultants
  • Healthcare Translation Agencies
  • Technology Vendors/Portal Service Providers
live chat software